Complications of Cushing's syndrome: state of the art.
Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A.
Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29. doi: 10.1016/S2213-8587(16)00086-3. Epub 2016 May 10.
Approach to the Patient with Subclinical Cushing's Syndrome.
Ivović M, Marina LV, Šojat AS, Tančić-Gajić M, Arizanović Z, Kendereški A, Vujović S.
Curr Pharm Des. 2020;26(43):5584-5590. doi: 10.2174/1381612826666200813134328.
Metabolic Syndrome in Cushing's Syndrome Patients.
Ferraù F, Korbonits M.
Front Horm Res. 2018;49:85-103. doi: 10.1159/000486002. Epub 2018 Apr 5.
Secondary hypertriglyceridemia.
Viñals C, Zambón D, Yago G, Domenech M, Ortega E.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:29-36. doi: 10.1016/j.arteri.2021.02.006.
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H.
Allergy Asthma Clin Immunol. 2013 Aug 15;9(1):30. doi: 10.1186/1710-1492-9-30.
Hypertension and Cardiovascular Mortality in Patients with Cushing Syndrome.
Nieman LK.
Endocrinol Metab Clin North Am. 2019 Dec;48(4):717-725. doi: 10.1016/j.ecl.2019.08.005. Epub 2019 Sep 19.
Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?
Koracevic G, Stojkovic M, Lovic D, Pavlovic M, Kostic T, Kutlesic M, Micic S, Koracevic M, Djordjevic M.
Curr Vasc Pharmacol. 2020;18(1):12-24. doi: 10.2174/1570161116666181005122339.
Subclinical Cushing's syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis.
Paschou SA, Kandaraki E, Dimitropoulou F, Goulis DG, Vryonidou A.
Endocrine. 2016 Feb;51(2):225-35. doi: 10.1007/s12020-015-0776-6. Epub 2015 Oct 24.
Pathophysiology of dyslipidemia in Cushing's syndrome.
Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M.
Neuroendocrinology. 2010;92 Suppl 1:86-90. doi: 10.1159/000314213. Epub 2010 Sep 10.
Management of dyslipidemia in Cushing's syndrome.
Greenman Y.
Neuroendocrinology. 2010;92 Suppl 1:91-5. doi: 10.1159/000314294. Epub 2010 Sep 10.
